NUVA Live Quote + News | RedianPro

NUVA — —

NUVA；24小时价格走势。

葛兰素史克逾90亿美元收购Nuvalent：肿瘤业务扩张下的资金博弈
葛兰素素克正进行谈判，拟以超过90亿美元收购生物技术公司Nuvalent，交易最快本周宣布。Nuvalent专注于开发癌症精准疗法，其核心产品包括ROS1抑制剂NUV-520和ALK抑制剂NVL-655，均处于临床阶段。此次收购将显著强化GSK的肿瘤管线。
2026-06-09

📊 在监控面板里跟踪 NUVA —— 添加到 watchlist，配合价格 + 舆情双触发的告警规则，命中即时通过 Telegram / 邮件推送。

🗂️ All Tools

RedianPro one-stop tool index — 22 dedicated function pages. Data auto-refreshes every 30 min to 1 hour.

📋BriefingTonight's pre-market read 📰Daily WrapWhat happened today 🌡️Sectors11 SPDR sector ETFs 📅Earnings14d earnings + FOMC 📝InsidersSEC Form 4 ≥ $1M 🏛️Fed MacroFOMC + Fed speeches 📈Yield Curve11 tenors + inversion 📊CFTC COTHedge fund positioning ₿Crypto12 coins + Fear/Greed ⛽CommoditiesGold / Oil / Ag 🐉China ADRsADR ⇆ HK arb 🔥WSB HeatRetail social Top 50 🏆LeaderboardMost-watched tickers 🚀52w HighMomentum signals 📉52w LowReversal candidates 🔎ScreenerMulti-dim filter ⚖️Compare30 metrics side-by-side 🧮CalculatorsDCF / IV / Sharpe 🤖AI Q&ANatural language query 🔍SearchSite-wide search 📚Glossary100+ EN-CN terms 📈PortfolioClient-side simulator 📑NewsDaily Chinese digest